GTM Playbook for Home Health Care Agencies in 2027

The revenue problem being solved

Home health is one of the few businesses where you cannot raise your price. Traditional Medicare sets the rate, Medicare Advantage plans negotiate downward from it, and Medicaid waiver programs pay whatever the state legislature funded that biennium. That single fact reorganizes everything about go-to-market: your only levers are volume (how many admissions you win), mix (which clinical groupings and admission sources those admissions carry), capture (how much of the allowable payment your documentation actually earns), and cost per visit (how efficiently clinicians reach patients). An agency that treats "sales" as brochures and lunch drops will lose to one that treats it as a throughput problem across those four levers.

CMS finalized a -1.023% permanent prospective payment adjustment for CY 2026, on top of a temporary downward adjustment, as the agency continued unwinding what it determined was budget-neutrality overpayment under PDGM. The practical read for an owner-operator: assume flat-to-declining revenue per period, indefinitely, and assume the wage index and cost of clinical labor keep rising. Every year you do not improve coding accuracy, LUPA control, or visit efficiency, your EBITDA compresses by roughly the gap between rate change and labor inflation. That gap has been negative for several consecutive years.

Stack the labor problem on top. Home care turnover has been reported near 79% industry-wide by Home Care Pulse (now Activated Insights), and skilled home health, while better, still runs punishing numbers — a clinician who leaves takes referral relationships, patient continuity, and roughly $8,000-$15,000 in replacement cost with them. Hospitals notice when a patient's third nurse in four weeks shows up not knowing the wound history. The staffing problem is not an HR problem; it is a referral retention problem wearing a badge.

The last structural pressure is competitive density. In most metro markets there are dozens of certified agencies chasing the same discharge planners, and the planner's decision takes about ninety seconds. They are looking at three things: can you take the patient today, do you have the discipline coverage (nursing, PT, OT, ST, MSW, aide), and will this patient bounce back to the ED inside thirty days. Everything in a serious GTM plan is a way of answering those three questions faster and more credibly than the agency that called them first.

Adjacent operators feel the same physics. Hospice, personal care, home infusion, DME, and outpatient therapy all draw from the same discharge funnel and the same clinical labor pool, so the playbook below transfers with adjustment — hospice trades PDGM for per-diem levels of care, personal care trades episode revenue for authorized hours, and DME trades clinical capture for documentation-of-medical-necessity capture. The choke point is identical: a referring institution deciding, under time pressure, whom to trust with a discharge.

Root-cause map

Most agencies misdiagnose their own bottleneck. Owners say "we need more referrals" when the actual leak is downstream — referrals arrive and get declined for capacity, or get accepted and then bleed revenue through soft coding and short visit counts. Before you hire a liaison, map the funnel end to end and find where volume actually dies. The map below is the diagnostic order that most reliably finds real money in a sub-$10M agency.

Work the map in order. Intake response is nearly free to fix and pays immediately: answer referral calls live during business hours, respond to portal referrals in minutes rather than hours, and give the planner a yes-or-no on the same call whenever staffing allows. A conditional yes with a named start-of-care window beats a maybe every time, because the planner's job is to close the discharge, not to find the perfect agency.

Capacity declines are the quietest killer. Every decline teaches the planner to call someone else first, and that habit is sticky for months. Track declines by reason, by referral source, and by discipline — if you are declining because you lack an OT in one zip cluster, that is a hiring requisition with a hard ROI attached, not a vague staffing complaint. Agencies that publish an internal weekly "declined referrals" review usually find that two or three specific gaps drive most of them.

Revenue capture is where the largest silent losses live. Under PDGM, payment turns on admission source (institutional versus community), period timing (first versus subsequent 30-day period), clinical grouping, functional impairment level, and comorbidity adjustment. A field nurse rushing OASIS at 9 p.m. after six visits does not optimize five interacting variables. A certified coder reviewing every OASIS before submission does, and the delta between careless and careful coding on the same patient is real money per period — not because you upcode, but because accurate coding captures what the patient's actual condition supports.

LUPA deserves its own line in the diagnosis. When visits in a 30-day period fall below the clinical grouping's threshold, the period pays per-visit instead of the bundled amount, and revenue collapses. LUPAs usually come from three causes: a plan of care written thinner than the patient needs, missed visits that nobody backfilled, or a discharge timed just badly enough to land under the threshold. All three are schedule-management failures, visible in the EMR days before they become billing losses — if someone is actually looking.

Cost per visit is mostly geography and turnover. Clinicians paid per visit are effectively paid nothing for drive time, so a scattered caseload is a pay cut they experience as unfairness. Build caseloads by zip cluster, not by whoever has an open slot, and the same per-visit rate suddenly reads as competitive. Rework is the hidden third cost: every chart returned for missing face-to-face documentation or an incomplete homebound narrative burns clinician time that generates no revenue at all.

Benchmarks and ranges

Numbers without context mislead, so treat these as directional operating targets rather than guarantees — wage index, payer mix, and acuity swing all of them by region. Under PDGM, national standardized 30-day base payment sits in the low $2,000s before case-mix and wage adjustment, with realized revenue per period commonly landing anywhere from roughly $1,700 to $3,400 depending on grouping, comorbidity tier, functional level, and whether the admission was institutional. Two agencies in the same city with identical volume can differ by 20% in revenue per period purely on coding discipline and patient mix.

LUPA rate is the cleanest single-number health check. Top-quartile operators hold it in the low single digits; agencies drifting past 8-10% are usually looking at six figures of annual leakage in a mid-size book. Chase it weekly, not monthly — by the time a monthly report shows it, the periods have closed.

Recertification rate is the recurring-revenue metric hiding in plain sight. A recertified patient is a second 30-day period with zero acquisition cost, and agencies with strong clinical outcomes and disciplined reassessment recert a substantially higher share of episodes than agencies that discharge on autopilot. The point is not to extend care beyond medical necessity — that invites audit exposure — it is to make sure a patient who still qualifies is actually reassessed rather than dropped because the schedule got busy.

Clinician productivity is where agencies most often trade next year for this quarter. Full-time RN field clinicians are commonly held to roughly the mid-to-high 20s in weekly visit points, with a start of care weighted heavier than a routine visit; therapists typically run somewhat higher visit counts because visits are shorter. Push the number materially above the local market and you will hit your revenue target for two quarters and then pay for it in turnover, documentation quality, and — eventually — survey findings.

Compensation in skilled home health is overwhelmingly per-visit for field staff, with rates varying widely by market and discipline: a start of care pays a multiple of a routine visit because it carries the full OASIS burden. Two rules travel everywhere. First, pay mileage at or near the federal rate; clinicians compare this number across agencies more than almost anything else. Second, pay the full rate during orientation. Underpaying a new hire for four weeks is a false economy against replacement cost.

Days sales outstanding decides whether growth kills you. Traditional Medicare pays quickly on clean claims; Medicare Advantage runs materially slower; Medicaid slower still. Since Medicare Advantage now covers a majority of Medicare beneficiaries, an agency's blended DSO has structurally worsened over the last several years even when its billing team got better. Hold enough cash or committed credit to cover multiple payroll cycles before adding census, because every new admission consumes cash weeks before it produces any.

Contract economics with managed care need a walk-away number, computed rather than felt. Take your fully loaded cost per visit — clinician pay, mileage, payroll burden, supervisory and back-office allocation — and refuse per-visit rates that do not clear it with margin, unless the volume genuinely fills capacity that would otherwise sit idle. Filling idle capacity at thin margin is a legitimate strategy; filling *booked* capacity at thin margin while turning away better-paying referrals is how agencies grow revenue and lose money simultaneously.

On the technology line, the certified EMR is the anchor decision and the hardest to reverse. The established platforms in skilled home health — WellSky, Homecare Homebase, Axxess, and MatrixCare — differ mainly in scale fit, mobile point-of-care quality, and analytics depth, and are priced by some mix of subscription, per-patient, and census tier plus implementation. Get quotes for your actual census; published ranges vary too much to plan against. Budget realistically for the bolt-on layer too: referral intake and document exchange, benchmarking against peer agencies, predictive readmission scoring, market-share intelligence on referral sources, and a simple CRM for liaison territory management. For a small agency the bolt-ons can approach the EMR line item itself, and skipping the referral-intake tool in particular tends to cost more in slow intake than it saves.

Trade-offs and alternatives

Certified coder versus outsourced coding. Bringing coding in-house gives you speed, direct feedback to clinicians, and institutional knowledge, but a certified coder is a real salary that a sub-$3M agency may not carry comfortably. Outsourcing is priced per OASIS and scales with volume, but the feedback loop to your field staff is weaker and turnaround adds days to billing. A common middle path: outsource initially, audit the vendor's work monthly, and bring it in-house once volume makes the salary cheaper per chart. Whatever you choose, do not let field nurses self-code without review — it is the single most reliably unprofitable staffing decision in the industry.

Liaison headcount versus clinical capacity. Owners under pressure hire salespeople because sales feels like the growth lever. If you are already declining referrals for capacity, hiring a liaison makes the decline problem worse and burns the referral relationships you just paid to build. Sequence it: fix intake responsiveness first (free), then add clinical capacity in the zip clusters where you decline most, and only then add referral development headcount. When you do pay liaisons on conversion, structure it conservatively and get it reviewed against Anti-Kickback Statute and Stark considerations — per-referral compensation tied to federal healthcare program business is legally fraught, and "everyone does it" is not a defense.

Broad geography versus tight radius. A wide service area looks like more addressable market and behaves like a margin leak. Drive time is unbilled, clinicians resent it, and scattered caseloads make same-day coverage for a call-out nearly impossible. Most agencies do better dominating a tight radius — high density per clinician, reliable coverage, planners who see you as the local default — than covering a large territory thinly. Expand by opening a second location with its own clinical core, not by stretching the first one.

Owning adjacent lines versus partnering. Hospice, personal care, home infusion, and outpatient therapy are natural extensions of the same patient journey, and each captures value you currently hand to someone else. Each also carries its own license, survey regime, payment model, and management attention cost. Hospice in particular is a genuinely different business — per-diem economics, distinct compliance exposure around eligibility and length of stay, and a different clinical culture — not a bolt-on to skilled home health. For most operators under a certain scale, a formalized bidirectional referral agreement with a trusted partner captures most of the continuity benefit at a fraction of the risk. Revisit the build-versus-partner call when you have management depth, not just census.

Remote monitoring versus more visits. Remote patient monitoring for heart failure and COPD cohorts is attractive because readmission performance is what buys preferred-provider standing with hospitals under readmission-penalty pressure. But RPM carries per-patient cost, requires someone to actually watch and act on alerts, and produces nothing if alerts route to a voicemail box. Run it as a pilot on a defined cohort, staff the monitoring explicitly, and measure your own thirty-day rehospitalization before and after rather than trusting a vendor's case study.

Growth by acquisition versus organic. Buying a certified agency buys you the certification, the referral relationships, and the staff — and also the prior owner's survey history, coding habits, and any audit exposure that has not surfaced yet. Diligence should read chart samples, not just financials, because a book built on aggressive coding reprices sharply when you clean it up. Organic growth is slower and safer; acquisition is faster and occasionally expensive in ways that show up eighteen months later.

Quality investment versus sales investment. Below a solid star rating and a defensible readmission number, sales spend advertises a weakness. Discharge planners talk to each other and remember bounce-backs. Fix clinical outcomes and documentation first; the marketing story writes itself afterward, and the same liaison converts at a materially higher rate carrying good numbers than bad ones.

Rollout plan

Sequencing matters more than ambition. The rollout below assumes an owner-operator with a certified agency, limited management bench, and finite cash — the common case. Each phase has a gate: do not start the next until the prior one measurably holds.

Phase one is people and plumbing. Your director of nursing and your coding/QA lead determine whether the agency survives its first survey and whether it earns what it bills. Hire those before anyone whose job title contains the word "sales." Lock the EMR contract with your real census in the quote, and stand up referral intake so documents from hospitals and SNFs land somewhere structured instead of a fax queue. Build the referral map yourself — every acute hospital, SNF, and relevant physician practice in radius, with named contacts, in a CRM you will actually maintain.

Phase two builds the engine. Set an internal response standard for referrals and measure against it daily, not monthly. Institute a weekly case conference where the DON, intake, and whoever handles referral development review every declined referral by reason and every period at LUPA risk — this single meeting does more for margin than most software purchases. Build a one-page quality leave-behind with your CMS Home Health Compare star rating, your thirty-day rehospitalization number, and your start-of-care commitment, and make sure every claim on it is true and current. Planners verify.

Phase three is margin. Audit coding results against your pre-coder baseline and put a number on the lift; if there isn't one, your coder or your process is wrong and you need to know that at ninety days, not at year end. Drive LUPA down toward the low single digits. Take your payer contracts through the walk-away math and start renegotiations on the worst ones — coming to that conversation with your own visit-level cost data changes the tone considerably. Pilot remote monitoring on a defined cardiac and pulmonary cohort with a named person responsible for acting on alerts.

Phase four is disciplined scale, and it is where most agencies hurt themselves. Add clinical capacity where your decline data says you lose referrals, then add referral development on top of capacity you can actually serve. Keep compliance ahead of growth: run a mock survey roughly every six months, audit a sample of charts weekly for face-to-face documentation, homebound status narrative, and therapy utilization consistency, and treat any condition-level exposure as an emergency. A Targeted Probe and Educate escalation into prepay review will strangle cash flow faster than any sales problem you have, and enrollment consequences from a serious survey finding can stop new admissions entirely.

One organizational note that carries the whole plan: the weekly review meeting is the mechanism, not the metrics dashboard. Dashboards report; meetings decide. Agencies that hold a disciplined thirty-minute weekly review of declines, LUPA risk, coding queue, and open documentation consistently outperform agencies with far better software and no meeting.

Related questions

How is home health different from personal care or private-duty agencies?

Skilled home health is Medicare-certified, physician-ordered, clinician-delivered, and paid per 30-day period under PDGM. Personal care and private-duty are non-medical, paid hourly by private funds, Medicaid waiver, or long-term care insurance, and typically require no certification survey — different economics, different sales motion entirely.

Should a new agency pursue Medicare Advantage contracts immediately?

Only after you know your fully loaded cost per visit. MA volume can stabilize census and fill idle capacity, but rates commonly sit below traditional Medicare's effective yield and payment runs slower. Contract selectively, model the cash impact, and keep a documented walk-away rate.

What single metric best predicts an agency's profitability?

Revenue per 30-day period, tracked alongside LUPA rate. Together they capture coding quality, patient mix, admission source, and schedule discipline. Census alone is misleading — agencies routinely grow admissions while revenue per period falls faster than volume rises.

Does a strong star rating actually increase referrals?

It removes objections more than it creates demand. Discharge planners use quality data to narrow the list; availability and responsiveness decide who gets the call. A strong rating gets you considered, and same-day capacity gets you the patient.

How much cash should an agency hold before adding census?

Enough to cover several payroll cycles, because every admission consumes clinician wages and mileage weeks before the claim pays. With Medicare Advantage and Medicaid stretching collections, undercapitalized growth is a leading cause of agency failure even when the book is profitable on paper.

FAQ

What is the biggest operational challenge for home health agencies in 2027?

Clinical staffing. Industry turnover reported by Home Care Pulse/Activated Insights has run near 79% across home care, and skilled disciplines compete directly with hospitals and outpatient settings for the same nurses and therapists. Competitive per-visit pay, mileage reimbursement at the federal rate, geographic caseloads that respect drive time, and manageable productivity expectations do more for retention than any recruiting campaign.

How do I actually earn referrals from hospital discharge planners?

Be fast, be available, and be verifiable. Answer referral calls live, give a same-call answer on capacity whenever possible, and commit to a start-of-care window you can meet consistently. Bring current, accurate quality data — star rating and thirty-day rehospitalization — and never overstate it, because planners check. Reliability across many discharges builds the default-choice habit that marketing cannot buy.

How does the CMS payment adjustment change what I should do differently?

Assume revenue per period stays flat or declines while labor costs rise, then manage the gap. Practically: get OASIS coded and reviewed by someone trained, hold LUPA to the low single digits, build schedules that match the clinical plan of care, and reduce unbilled drive time through geographic caseloads. None of that involves changing clinical care — it involves capturing what the care you already deliver actually supports.

What technology should a small agency prioritize first?

One certified EMR — WellSky, Homecare Homebase, Axxess, or MatrixCare are the established choices — selected for your census size and mobile point-of-care quality, then a referral intake and document exchange layer so hospital and SNF paperwork arrives structured. Benchmarking, predictive readmission scoring, and market-share intelligence are valuable but come after the core two are running cleanly.

Is direct-to-consumer marketing worth any budget at all?

A modest amount. Most admissions originate from institutional referral sources, so the marketing dollar works hardest at the discharge desk. That said, families increasingly search agencies by name after a planner offers a choice, so a clear website with services, service area, coverage hours, and current quality data protects referrals you have already earned. Treat it as conversion support, not lead generation.

What compliance exposure most often blows up an otherwise healthy agency?

Documentation. Face-to-face encounter records, homebound status narrative, and therapy utilization consistency are exactly what Targeted Probe and Educate, UPIC, and RAC reviews examine. A failed escalation into prepay review chokes cash flow for months, and a condition-level survey finding can jeopardize your ability to admit at all. Weekly internal chart audits and a mock survey twice a year cost a fraction of the exposure.

Sources

• CMS — Home Health Prospective Payment System
• CMS — Patient-Driven Groupings Model (PDGM)
• Medicare Care Compare — Home Health Agencies
• Federal Register — Medicare and Medicaid Programs: Home Health Prospective Payment System Rate Updates
• MedPAC — Home Health Care Services Payment Basics
• HHS Office of Inspector General — Home Health Compliance Resources
• KFF — Medicare Advantage Enrollment and Spending
• UCSF Health Workforce Research Center — Staff Turnover in Home Health
• Bureau of Labor Statistics — Home Health and Personal Care Aides
• CMS — Home Health Agency Center (conditions of participation, survey)

Related on PULSE

• [GTM Playbook for Senior In-Home Care Agencies in 2027](/knowledge/gp0322)
• [How do you build a caregiving and home health software (CareAcademy / WellSky) go-to-market motion in 2027?](/knowledge/gp0111)
• [GTM Playbook for Home Inspectors in 2027](/knowledge/gp0362)
• [GTM Playbook for Custom Home Builders in 2027](/knowledge/gp0370)
• [How do you build the GTM playbook for a tree care and gutter services operator in 2027?](/knowledge/gp0165)